SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000898430-97-004550
Filing Date
1997-10-28
Accepted
1997-10-28 00:00:00
Documents
4
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D DATED 10-01-1997 SC 13D 20625
2 STOCK & WARRANT AGREEMENT DATED 10-01-1997 EX-7.1 42807
3 WARRANT AGREEMENT DATED 10-01-1997 EX-7.2 42738
4 REGISTRATION RIGHTS AGREEMENT DATED 10-01-1997 EX-7.3 75705
  Complete submission text file 0000898430-97-004550.txt   184223
Mailing Address 1840 DEHAVILLAND DR. MAIL STOP 10-1-B-512 THOUSAND OAKS CA 91320-1789
Business Address 1840 DEHAVILLAND DR THOUSAND OAKS CA 91320-1789 0854471000
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Subject) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45277 | Film No.: 97702242
SIC: 2834 Pharmaceutical Preparations